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ABSTRACT
Objectives: To compare expectant management with early planned labor induction in pregnancies complicated by late 
preterm pre-labor rupture of membranes (PPROM).
Material and methods: A retrospective file review was conducted in a single tertiary center from January 2015 to Sep-
tember 2019. Singleton pregnancies complicated by late PPROM at 34–36 completed weeks of gestation were enrolled. 
We compared maternal and neonatal complications between expectant management and early planned labor induction. 
Results: We retrospectively assigned 41 women to the expectant management group and 39 to the early planned labor 
induction group. No difference was found in the mode of delivery between the groups. Women in the expectant manage-
ment group had a longer antepartum hospital stay compared with the induction group (median of three versus one day, 
p < 0.01). Neonates were delivered at a more advanced gestational age in the expectant management group compared 
with that in the induction group (35 5/7 versus 35 2/7 weeks, p < 0.01). In the induction group, 74.4% of the neonates were 
admitted to the intensive care unit (ICU), and 66.7% received antibiotics compared with 51.2% of neonates admitted to ICU 
and 29.3% receiving antibiotics in the expectant management group (p = 0.04 and p < 0.01, respectively). 
Conclusions: In pregnancies complicated by late PPROM, early labor induction was associated with a shorter antepartum 
maternal hospital stay but a higher neonatal ICU admission rate and more frequent antibiotic administration than expect-
ant management. We consider expectant management to be an acceptable alternative to early labor induction in PPROM.
Key words: cesarean section; chorioamnionitis; labor induction; neonatal respiratory distress syndrome; premature rupture 
of membrane (pregnancy)
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INTRODUCTION
Late preterm pre-labor rupture of membranes (PPROM) 
complicates one percent of pregnancies between the 
34 0/6 and 36 6/7 weeks of gestation [1]. A non-reassuring 
fetal status, cord prolapse, placental abruption, and cho-
rioamnionitis are all indications for prompt delivery. How-
ever, the optimal approach to manage women with late 
PPROM but without an indication for prompt delivery is 
still discussed. The American College of Obstetricians and 
Gynecologists endorse both expectant management and 
immediate delivery [2]. The Royal College of Obstetricians 
and Gynecologists considers expectant management to be 
the best practice management [3].
A recent meta-analysis [4] of 2,563 mothers showed 
that neonates who were delivered immediately were more 
frequently diagnosed with respiratory distress syndrome, 
admitted to the neonatal intensive care unit (NICU), and kept 
in hospital for prolonged periods of time. In the immediate 
delivery group, maternal outcomes exhibited a reduced 
risk of antepartum hemorrhage and chorioamnionitis but 
an increased rate of cesarean sections (CS).
A multicenter randomized trial demonstrated a signifi-
cant decrease in neonatal respiratory morbidity in mothers 
at risk for late preterm delivery who were treated with one 
course of corticosteroids [5]. Still, to date, there is insufficient 
evidence regarding the long-term neurodevelopmental 
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implications and metabolic risks of such treatment in in-
fants [6, 7].
At our institution, we induced labor in all women with 
late PPROM who then received antibiotic prophylaxis dur-
ing labor without antenatal corticosteroids administration 
until 2016. Since 2016, we adopted a different protocol 
and started offering expectant management that included 
corticosteroids to women with uncomplicated PPROM until 
37 0/7 weeks of gestation. 
The aim of this study was to compare the maternal and 
neonatal outcomes between expectant management and 
delivery at 34 weeks of gestation in women with PPROM at 
our institution.
MATERIAL AND METHODS
The protocol of this retrospective study was approved by 
the local Institutional Review Board (Helsinki Committee) of 
the Galilee Medical Center, Nahariya, Israel (date of approval 
April 28, 2019, number 0041-19-NHR). 
We reviewed the records of 186 women with late PPROM 
at 34–36 completed weeks of gestation who were admit-
ted to our hospital between January 2015 and September 
2019. The diagnosis of PPROM was based on the following 
criteria in either the history or during physical examination: 
a history of leaking fluid and pooling of amniotic fluid ob-
served on sterile speculum examination. If there was no clear 
pooling, the AmniSure ROM test (AmniSure International 
LLC, Boston, MA, US) was used, an immune-chromatography 
method to detect traces of placental alpha microglobu-
lin-1 protein in the vaginal fluid to confirm the diagnosis.
The exclusion criteria consisted of multiple pregnancy, 
fetal malformations, meconium-stained amniotic fluid, an-
hydramnios, non-reassuring fetal status, placental abrup-
tion, suspected chorioamnionitis, and active labor or ur-
gent CS upon admission. Furthermore, our indications for 
immediate delivery before the completion of 37 weeks in 
the expectant management group were a non-reassuring 
fetal status, cord prolapse, anhydramnios, placental abrup-
tion, and chorioamnionitis. In addition, labor was induced 
if patients refused to continue the conservative follow-up. 
Based on these criteria, we excluded 58 women with active 
labor, three with fetal malformations, 57 who underwent 
immediate cesarean section, and eight in whom labor was 
induced immediately.
Eventually, 80 cases were enrolled in the study. The pa-
tient selection process is described in Figure 1. We divided 
these patients into two groups: The planned labor induction 
group consisted of 39 women who underwent planned 
labor induction with oxytocin (if they did not experience 
spontaneous labor within 12 hours after PPROM). The ex-
pectant management group consisted of 41 women who 
were monitored and managed expectantly until either spon-
taneous delivery or 37 0/7 weeks, whatever occurred earlier. 
All women were hospitalized from the time of diagnosis 
until delivery.
The expectant management included:
1. Maternal monitoring for signs of infection including 
clinical parameters (maternal temperature, presence 
of uterine tenderness, frequency of contractions, and 
maternal and fetal heart rate) and laboratory parameters 
(monitoring white blood cell counts and C-reactive pro-
tein every 48 hours).
2. Fetal monitoring included fetal movement count and 
performing six nonstress tests daily and a biophysical 
profile twice a week. Oligohydramnios was not consid-
ered to be an indication to induce labor.
3. Patients were treated with prophylactic antibiotics for 
one week, and, from 2017, they additionally received 
Figure 1. Selection of participants for this comparison of outcomes between early induced labor with expectant management in women with late 
preterm pre-labor rupture of membranes (n = 80); PPROM — preterm pre-labor rupture of membrane
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one course of antenatal corticosteroids at admission if 
they had not received it previously.
4. Screening for infection included a recto-vaginal swab 
for a group B strep test and a urine culture that were 
both obtained on admission. 
We recorded information on maternal demographics, 
the obstetric history, including previous pre-term delivery 
or PPROM, and the current pregnancy follow-up, including 
cervical shortening and antenatal corticosteroid adminis-
tration. Furthermore, we recorded the length of the latency 
period (time from PPROM until delivery), maternal and fetal 
monitoring data, whether labor progressed spontaneously 
or had been induced for medical indications, mode of deliv-
ery, rates of antepartum and postpartum hemorrhage (APH 
and PPH), antepartum fever, intrapartum chorioamnionitis, 
placental and membrane culture results, antepartum and 
postpartum hospitalization duration, total hospital stay, 
postpartum antibiotic administration, and placental his-
topathological findings. The neonatal outcomes included 
the Apgar score, birth weight, cord pH, neonatal respiratory 
support, hospitalization length, data concerning infectious 
disease evaluation at the NICU, and any complications re-
lated to prematurity, such as respiratory distress syndrome, 
transient tachypnea of newborn, hypoglycemia, intraven-
tricular hemorrhage, necrotizing enterocolitis, hyperbiliru-
binemia, and stillbirth.
Statistics
Continuous variables are presented as the mean ± stand-
ard deviation or as median and range. Qualitative variables 
are presented as frequencies and percentages. Compari-
sons of continuous variables between the two groups were 
performed with either the independent sample t-test or 
Mann-Whitney test based on the sample size of the groups 
and the variables’ distribution shape. Categorical variables 
were analyzed using Pearson’s chi-square or Fisher’s exact 
test. A two-tailed p-value < 0.05 was considered statistically 
significant.
All statistical analysis was conducted by the statistical 
department at Galilee Medical Center using IBM SPSS Statis-
tics for Windows, version 25.0 (IBM Corp., Armonk, NY, USA).
RESULTS
The baseline characteristics of the two groups are rep-
resented in Table 1. There were no differences in maternal 
age, gravity, parity, and the gestational age at admission 
was similar for the two groups (median of 35 1/7 weeks). 
A non-significant trend towards having a history of PPROM 
or preterm delivery was noted in the induction group com-
pared with the expectant management group (23.1% versus 
7.3%, respectively, p = 0.06). In the expectant management 
group, 78% of women received antenatal steroids compared 
with only 7.7% in the labor induction group (p < 0.01). 
Table 1. Baseline characteristics of 80 women with late preterm pre-labor rupture of membranes
Expectant management group 
(n = 41)
Labor induction group
(n = 39) p value
Maternal age, years (mean ± SD) 30.20 ± 6.56 30.59 ± 5.48 0.77
Gravity (median, range) 2 (1–7) 3 (1–8) 0.21
Parity (median, range) 1 (1–5) 2 (1–4) 0.19
ART-conceived, n (%) 4/41 (9.8) 1/39 (2.6) 0.36
History of PPROM or preterm delivery, n (%) 3/41 (7.3) 9/39 (23.1) 0.06
Cervical shortening, n (%) 2/40 (4.9) 3/39 (7.7) 0.67
Previous cesarean delivery, n (%) 4/41 (9.8) 5/39 (12.8) 0.73
Thrombophilia, n (%) 2/41 (4.9) 2/39 (5.1) 1.0
Hypertensive disorders, n (%) 1/41 (2.4) 0/39 (0) 1.0
Diabetes, n (%) 7/41(17.1) 2/39 (5.1) 0.15
Positive group B streptococcus vaginal swab at admission, n (%) 5/23 (21.7) 0/11 (0) 0.15
Gestational age at admission, weeks (mean ± SD) 35.13 ± 0.61 35.10 ± 0.69 0.87
White blood cell count, median (range) 11.25 (6.01–34.0) 11.08 (7.59–15.85) 0.87
C-reactive protein, median (range) 8 (0.90–46.10) 10 (0.40–52.0)
Steroids given during pregnancy, n (%) 9/41 (22) 5/39 (12.8) 0.38
Steroids given at admission, n (%) 32/41 (78) 3/39 (7.7) < 0.01
Duration of PPROM, hours (median, range) 80.80 (25.67–302.60) 20.18 (12.38–75.30) < 0.01
ART — assisted reproductive technology; PPROM — preterm pre-labor rupture of membrane; SD — standard deviation
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The median duration of PPROM in the expectant management 
group was significantly longer compared with the induction 
group (80.80 versus 20.18 hours, respectively, p < 0.01).
The maternal outcomes are detailed in Table 2. Women 
in the expectant management group had a longer antepar-
tum hospital stay than the induction group (median of three 
versus one day, p < 0.01), with no significant difference 
in the postpartum hospital stay. Women in the induction 
group had a shorter total hospital stay than the expectant 
management group (median of four versus seven days, 
respectively, p < 0.01).
In the expectant management group, 24 (58%) of the 
women had spontaneous labor prior to 37 weeks, two 
(4.8%) underwent induction when they had completed 
37 0/7 weeks, and 17 (36 %) underwent labor induction 
prior to 37 weeks for the following reasons: eight (19.5%) 
for suspected fetal distress, four (9.7%) on maternal request, 
two (4.8%) because of severe oligohydramnios, and one 
(2.4%) because of suspected chorioamnionitis.
No significant difference was found between the groups 
in the rates of positive cultures, histological chorioamnio-
nitis, and the different pathogens. Escherichia coli (E. coli) 
was the most frequently isolated organism in both groups, 
followed by Enterobacter faecalis. In addition, Klebsiella pneu-
moniae, Bacteroides vulgaris, Enterobacter cloacae complex, 
Bacteroides fragilis and Proteus mirabilis were also isolated. 
The neonatal outcomes are shown in Table 3. Neonates 
were delivered at a more advanced gestational age in the ex-
pectant management group compared with the induction 
group (35 5/7 versus 35 2/7 weeks, respectively, p < 0.01). 
None of the neonates had a 5-minute Apgar score of less 
than 7 or pH < 7.1 in either group. In the induction group, 
74.4% of the neonates were admitted to the NICU compared 
with 51.2% in the expectant management group (p = 0.04). 
In the induction group, 66.7% of the neonates received 
antibiotics compared with 29.3% in the expectant manage-
ment group (p < 0.01). 
No case of stillbirth or neonatal death was reported in 
our study population.
DISCUSSION
In our population of women with PPROM, planned labor 
induction was related to higher neonatal ICU admission and 
antibiotic administration rates than expectant management, 
while the latter resulted in a longer maternal hospital stay.
These results are in accordance with the findings of 
previous studies. The PPROMT study [8] was a randomized 
controlled trial comparing immediate delivery versus ex-
pectant management in 1839 women with late PPROM 
and reported that, compared to labor induction, expectant 
management resulted in a longer maternal hospital stay 
since 75% of these mothers were managed in the hospital 
until delivery. In our study, all women undergoing expect-
ant management were hospitalized upon admission and, 
consequently, had longer antepartum and total hospital 
stays but no difference in the postpartum stay. 
Table 2. Maternal outcomes in 80 pregnancies with late preterm pre-labor rupture of membranes
Expectant management group 
(n = 41)
Labor induction group
(n = 39) p value
Antepartum LOS in hospital, days, median (range) 3 (1–13) 1 (0–3) < 0.01
Postpartum LOS in hospital, days, median (range) 3 (1–12) 3 (2–7) 0.85
Total LOS in hospital, days, median (range) 7 (3–23) 4 (3–7) < 0.01
Antepartum hemorrhage, n (%) 1 (2.4) 2 (5.1) 0.61
Antepartum fever, n (%) 4 (9.8) 2 (5.1) 0.67
Intrapartum chorioamnionitis, n (%) / (7.3) 1 (2.6) 0.61
Mode of delivery
Vaginal delivery, n (%) 31 (75.6) 32 (82.1)
0.78Vacuum extraction, n (%) 1 (2.4) 0
Cesarean section, n (%) 9 (22.0) 7 (17.9)
Postpartum hemorrhage, n (%) 0 (0) 3 (7.7) 0.11
Urinary tract infection, n (%) 1/20 (4.8) 0 1.00
Postpartum antibiotic administration, n (%) 4 (9.8) 4 (10.3) 1.0
Any positive culture*, n (%) 38/40 (95.0) 34 (87.2) 0.26
Histological chorioamnionitis, n (%) 9/24 (37.5) 6/27 (22.2) 0.35
LOS — length of stay; *At least one positive culture of one of the following: uterus, placenta, membranes, or umbilical cord
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However, in contrast to the PPROMT study [8] and 
a recent meta-analysis [4] that showed a higher risk of 
APH and PPH with expectant management, in our study, 
there was no difference in the frequency of APH or PPH in 
this group compared to labor induction. These studies in-
cluded multiple pregnancies, and women who presented 
with ruptured membranes earlier in pregnancy became 
eligible upon reaching 34 weeks of gestation and were 
then followed beyond 34 0/7 weeks. The different inclu-
sion criteria and study design could explain the differences 
in the results since multiple pregnancies are considered 
at risk for PPH.
Previous studies reported a higher risk of clinical and 
histological chorioamnionitis [9, 10] in women who under-
went expectant management. In contrast, we did not find 
any difference in maternal infections between the groups. 
All patients in our study received antepartum antibiotics, 
either intravenously, orally, or both. In the PPROMT study 
[8], a similar proportion (86 %) of patients in both groups 
received antepartum antibiotics, but women in the expect-
ant management group showed higher rates of intrapartum 
fever and postpartum antibiotic use. A recent meta-analysis 
[11] showed that the use of prophylactic antibiotics is effec-
tive in reducing maternal infections in women undergoing 
expectant management. This discordance between the find-
ings could be related to our small sample size. 
PPROMEXIL [9] and PPROMEXIL-2 [10] were randomized 
controlled trials conducted in the Netherlands and com-
pared labor induction versus expectant management 
in non-laboring women with PPROM between 34 and 
37 weeks. Like our findings, no difference in the CS rate 
was found between the two approaches. Other studies [4, 8] 
found higher CS rates in women with immediate delivery 
induction. The fact that the Dutch trials involved multiple 
centers in one country [9, 10], while the other trial [8] in-
volved 65 centers in 11 countries. could have affected the 
CS rate. Both were multicenter studies, but the difference 
most probably results from different national approaches. 
For instance, in the PPROMEXIL-2 trial [10], only 13% of the 
patients in the induction group underwent CS compared 
with a twice as high rate of 26% in the PPROMT study [8]. 
However, the indications for CS were not reported in these 
studies, making it difficult to draw definite conclusions con-
cerning the differences in CS rates.




(n = 39) p value
Gestational age on delivery, weeks (median ± SD) 35.72 (± 0.76) 35.25 (± 0.69) < 0.01
Birth weight, g (median ± SD) 2576.95 (± 311.21) 2475.18 (± 263.22) 0.11
Intrauterine growth restriction, n (%) 0 (0) 2 (5.1) 0.23
Apgar score at 5 min, median (range) 9 (7–10) 9 (8–10) 0.84
Umbilical cord pH, median (range) 7.30 (7.26–7.40)
7.31 
(7.26–7.37) 0.58
Need for resuscitation at birth, n (%) 2 (4.9) 1 (2.6) 1.00
Admission to NICU, n (%) 21 (51.2) 29 (74.4) 0.04
LOS in NICU, days, median (range) 8 (2–23) 8 (2–17) 0.49
Fever at birth 1 (2.4) 2 (5.1) 0.61
Antibiotics administration, n (%) 12 (29.3) 26 (66.7) < 0.01
Neonatal sepsis, n (%) 0 0 –
Pneumonia, n (%) 0 1 (2.6) 0.48
Respiratory distress syndrome, n (%) 0 0 –
Transient tachypnea of newborn, n (%) 3 (7.3) 1 (2.6) 0.61
Invasive ventilation, n (%) 2 (4.9) 1 (2.6) 1.00
Non-invasive ventilation, n (%) 2 (4.9) 2 (5.1) 1.00
Surfactant administration, n (%) 0 1 (2.6) 0.48
Hypoglycemia, n (%) 2 (4.9) 2 (5.1) 1.00
Intraventricular hemorrhage, n (%) 0 2 (5.1) 0.23
Necrotizing enterocolitis, n (%) 0 0 –
Hyperbilirubinemia, n (%) 20 (48.8) 25 (64.1) 0.18
SD — standard deviation; LOS — length of stay; NICU — neonatal intensive care unit
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Similarly, to previous studies [9, 10], pregnancy was pro-
longed by three days in our mothers with expectant man-
agement, and their newborns were less likely to be admitted 
to the NICU. Still, the length of stay of neonates admitted to 
the NICU was similar in both groups. These findings are in 
line with previous studies [4, 9]. Neonatal admission to the 
NICU results in higher costs and might increase the risk of 
nosocomial infections [12], but also interrupts the bonding 
process and increases parental stress [13]. 
We did not find any difference in neonatal infectious 
complications (e.g., fever at birth, positive blood cultures, 
or sepsis) between the groups, but more neonates in the 
planned induction group received antibiotics than in the 
expectant management group. Previous studies did not find 
any difference in neonatal sepsis, positive blood cultures, or 
antibiotic administration [4, 8, 9]. Furthermore, although in 
our study neonates in the expectant management group 
were born at an advanced gestational age, expectant man-
agement neither reduced neonatal respiratory morbidity 
nor affected the need for ventilation. On the opposite, pre-
vious studies [4, 8, 11] showed benefits for expectant man-
agement, whereas immediate delivery increased the risk of 
respiratory distress and mechanical ventilation. 
Our data is underpowered to identify differences in 
neonatal mortality and morbidity between the two ap-
proaches, but a recent meta-analysis reported that planned 
early birth increased the risk of neonatal death (RR 2.55, 95% 
CI 1.17–5.56) without reducing the risk of neonatal sepsis 
(RR 0.93, 95 % CI 0.66–1.30) [11].
In our study, 78% of the women in the expectant man-
agement group received one course of steroids at admission 
compared with only 7.7% of women in the induction group. 
This disparity resulted from the new approach introduced in 
2017 when we started administering one course of steroids 
in women with late PPROM [5, 14–16]. Despite this, steroid 
administration in gestation periods of ≥ 34 0/7 weeks is 
still controversial, mainly because of concerns about the 
long-term neurodevelopmental outcomes in newborns [17].
One of the strengths of this study is that we examined 
a clearly defined population of women with late PPROM 
between 34 0/7 and 36 6/7 weeks. Previous studies [8, 9, 12] 
included women with lower gestational ages at PPROM 
(< 34 0/7) and were followed from 34 weeks onward. Fur-
thermore, detailed maternal and fetal data were recorded 
over a period of five years. Unlike previous studies, our data 
were collected from a single center with defined standards 
of clinical practice, treatment, and care. Despite the relatively 
small sample size, we could demonstrate a distinct differ-
ence in neonatal outcomes, such as higher NICU admission 
rates and more frequent neonatal antibiotic treatment in 
the induction group.
Our study has several limitations. As a retrospective 
cohort study, risk of confounding bias remains even with 
the use of multivariable statistical techniques. Further-
more, it was underpowered to detect significant differ-
ences in certain maternal and fetal complications, such 
as neonatal sepsis and mortality, because of the small 
sample size. 
CONCLUSIONS
We found that early planned labor induction in preg-
nancies complicated by late PPROM was associated with 
a shorter antepartum maternal hospital stay, but longer 
neonatal ICU stay and higher rates of antibiotic treatment 
than expectant management. Thus, we consider expectant 
management to be a safe and acceptable alternative to early 
labor induction in PPROM.
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